Filing Flows › Petmed Express (PETS) › Stock forecast & fair value
Petmed Express (PETS) stock forecast and price target
Petmed Express (PETS) trades at $1.22. One analyst's price target is $1.40 (+15%).
Petmed Express' latest quarter
Petmed Express, Q1 FY27: revenue $41.0M (-20% year over year), operating margin -15.2%, net loss $6.1M, operating cash flow −$7.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for PETS stock?
One analyst's 12-month target is $1.40, +15% from $1.22. The average rating is none.
Does Petmed Express usually beat earnings estimates?
It beat the consensus EPS estimate in 0% of the quarters on record.
Is PETS stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.